Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Antiviral Chemistry & Chemotherapy|March 3, 2001
Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitroP G Hoggard, S D Sales, S Kewn, et al.Contraception|March 1, 1993
Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisolJ Hammerstein, E Daume, A Simon, et al.HIV Medicine|May 15, 2014
Therapeutic drug monitoring of atazanavir/ritonavir in pregnancyL J Else, V Jackson, M Brennan, et al.Ciba Foundation Symposium|January 1, 1980
Influence of environmental chemicals on drug therapy in humans: studies with contraceptive steroidsA M Breckenridge, D J Back, K Cross, et al.AIDS (London, England)|August 16, 2001
P-Glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: potential for accelerated viral drug resistance?K Jones, P G Bray, S H Khoo, et al.British Journal of Clinical Pharmacology|April 12, 2001
The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenzS M Clarke, F M Mulcahy, J Tjia, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2001
Pharmacokinetic interactions of nevirapine and methadone and guidelines for use of nevirapine to treat injection drug usersS M Clarke, F M Mulcahy, J Tjia, et al.Contraception|September 1, 1979
An investigation of the pharmacokinetics of ethynylestradiol in women using radioimmunoassayD J Back, A M Breckenridge, F E Crawford, et al.The Journal of Antimicrobial Chemotherapy|September 5, 2001
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavirS Taylor, D J Back, S M Drake, et al.The Journal of Antimicrobial Chemotherapy|August 15, 2003
Effect of protease inhibitor-containing regimens on lymphocyte multidrug resistance transporter expressionJ Ford, E R Meaden, P G Hoggard, et al.Pageof 19